Magnentum Founders Speak on Professional Submission Writing and Technology
Posted By: Magnentum | Posted On: 21st May 2016
Ken Robinson and Maneet Singh, the founders of Magnentum highlighted other important topics making rounds in the industry too. One of which was the need to integrate technology in different phases of drug development, especially for data collection, data management, protocol design, training, recruiting and the other steps that follow. Ken, who has over 35 years of experience in Medical writing and regulatory expertise for clinical trials enunciated on the subject of quality submission writing and how do they make a difference. He spoke about how the quality of medical writing has declined in the past few years and its impact. It was quite an interactive session with questions pouring in from the audience, mainly representatives of different companies. While Maneet elaborated on the rising need of harmonizing tech with the clinical research services. He also introduced ADI Group of companies, a firm founded by him, working in syncing technology with the different sectors of drug development. He spoke about the current five areas services his company caters to which actually form a combination of more than 75 services.